Life sciences briefing: Friday, Jan. 18, 2007
TODAY’S HEADLINES:
Ulthera receives $23M for cosmetic ultrasound devices (release)
Senexis raises £2.9M for Alzheimer’s drugs (PDF release)
Elixir Pharma postpones IPO (IPO Home)
Cancer Therapeutics names Randall Riggs as CEO (release)
Ulthera receives $23M for cosmetic ultrasound devices — Ulthera, a Mesa, Ariz., startup developing ultrasound systems for cosmetic… Continue Reading